Healthcare provider profile · identity verified

Lance S Lim, MD

General Practice · WESSINGTON SPRINGS, SD · NPI 1013914209

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	434	54
Furosemide	Furosemide	400	49
Atorvastatin Calcium	Atorvastatin Calcium	372	68
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	285	37
Lisinopril	Lisinopril	233	48
Gabapentin	Gabapentin	197	38
Losartan Potassium	Losartan Potassium	172	30
Metformin Hcl	Metformin Hcl	172	33
Rosuvastatin Calcium	Rosuvastatin Calcium	170	36
Amlodipine Besylate	Amlodipine Besylate	165	33
Omeprazole	Omeprazole	160	39
Spironolactone	Spironolactone	140	23
Pantoprazole Sodium	Pantoprazole Sodium	135	17
Metoprolol Succinate	Metoprolol Succinate	133	24
Eliquis	Apixaban	129	12
Hydrochlorothiazide	Hydrochlorothiazide	124	28
Potassium Chloride	Potassium Chloride	122	24
Citalopram Hbr	Citalopram Hydrobromide	120	23
Trazodone Hcl	Trazodone Hcl	104	14
Carvedilol	Carvedilol	103	16
Oxycodone Hcl	Oxycodone Hcl	103	19
Tamsulosin Hcl	Tamsulosin Hcl	99	16
Tramadol Hcl	Tramadol Hcl	99	19
Clopidogrel	Clopidogrel Bisulfate	88	17
Metoprolol Tartrate	Metoprolol Tartrate	80	16
Alprazolam	Alprazolam	75	11
Lorazepam	Lorazepam	75	11
Simvastatin	Simvastatin	71	16
Ozempic	Semaglutide	69	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	64	suppressed
Prednisone	Prednisone	62	31
Mirtazapine	Mirtazapine	61	suppressed
Fentanyl	Fentanyl	59	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	suppressed
Clonazepam	Clonazepam	58	suppressed
Sertraline Hcl	Sertraline Hcl	58	11
Albuterol Sulfate Hfa	Albuterol Sulfate	55	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	suppressed
Allopurinol	Allopurinol	53	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Xarelto	Rivaroxaban	52	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	14
Latanoprost	Latanoprost	47	suppressed
Lovastatin	Lovastatin	47	12
Sucralfate	Sucralfate	47	suppressed
Alendronate Sodium	Alendronate Sodium	46	suppressed
Atenolol	Atenolol	45	suppressed
Divalproex Sodium	Divalproex Sodium	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Carisoprodol	Carisoprodol	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	suppressed
Oxycontin	Oxycodone Hcl	39	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Topiramate	Topiramate	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Budesonide	Budesonide	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Onfi	Clobazam	34	suppressed
Azithromycin	Azithromycin	33	31
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	33	suppressed
Sulfasalazine	Sulfasalazine	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Cephalexin	Cephalexin	30	18
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	29	suppressed
Meloxicam	Meloxicam	29	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Risperidone	Risperidone	26	suppressed
Fluconazole	Fluconazole	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Diazepam	Diazepam	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	18
Temazepam	Temazepam	24	suppressed
Torsemide	Torsemide	24	suppressed
Lagevrio (Eua)	Molnupiravir	23	23
Venlafaxine Hcl	Venlafaxine Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Amoxicillin	Amoxicillin	22	15
Calcitriol	Calcitriol	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	13
Pregabalin	Pregabalin	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Glipizide	Glipizide	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Tegretol Xr	Carbamazepine	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Finasteride	Finasteride	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Jardiance	Empagliflozin	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Famotidine	Famotidine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Cefdinir	Cefdinir	11	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error